The US Federal Food and Drug Administration, (FDA) is refusing to give a licence to a new weight loss drug until further clinical tests have been carried out. The FDA is worried that Contrave, a new combo medication has been thoroughly evaluated for any cardiovascular risks. Contrave which is manufactured by pharmaceutical company Orexigen contains […]